The forecasted diphtheria, tetanus toxoid, and pertussis third dose (DTP3) immunization coverage in China from 2024 to 2028 consistently remains at 99% for children aged one year old. This stability reflects a continuation of the immunization coverage level as seen in 2023. With the forecasted coverage retaining a high level, the year-on-year variation remains zero, signifying steady immunization practices. The last five years' compound annual growth rate (CAGR) is also zero, underscoring the level maintenance of DTP3 immunization.
Looking ahead, future trends to watch for include potential shifts in vaccination policy, introduction of new vaccines, or changes in public health infrastructure which may influence immunization rates. Additionally, monitoring the impact of global health trends and vaccine supply chains could provide insights into future coverage adjustments.
